It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

By his estimate, that means AI has been around at Sanofi for about a third of the "discovery" process for some drugs. That ...

Pharmaceutical company Novo Nordisk has announced it ... Zilbermint highlights Lantus (insulin glargine) as a good option. Although Levermir and Lantus have different chemical structures, both ...

Generic drugmaker Viatris has become the first company to secure FDA approval ... reference product – namely Sanofi's once-daily insulin Lantus. Semglee has been approved for over a year as ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... Last year, Viatris became the first company to secure FDA approval for a biosimilar product ...

Telehealth platform GoodRx has become the latest company to offer people with ... patients a coupon for to a 30-day supply of Lantus, an insulin glargine injection and Sanofi's most widely ...

Coverage can vary among plans sponsored by the same insurance company ... as Lantus or Novolog, a pop-up box notes, “Your drug has a generic” that may cost less. In the case of insulin ...

that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...

The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood thinners, spends about three billion euros, or $3.1 billion, on discovery within that timeframe, Hudson said.